Related Experiment Videos
Albumin-corrected anion gap and mortality risk in cardiorenal syndrome: Insights from a nationally representative
Hongman Li1,2, Xing Huang2,3, Shengyong Si1,2
1Department of Hypertension, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Insights
Higher albumin-corrected anion gap (ACAG) levels in cardiorenal syndrome (CRS) patients are linked to increased mortality risk. This finding highlights ACAG as a potential tool for risk stratification in nephrology.
Area of Science:
- Nephrology
- Cardiology
- Clinical Chemistry
Background:
- The prognostic value of the albumin-corrected anion gap (ACAG) in cardiorenal syndrome (CRS) is not well-established.
- CRS involves complex interactions between cardiac and renal systems, impacting patient outcomes.
Purpose of the Study:
- To investigate the association between ACAG levels and mortality in a large, nationally representative cohort of CRS patients.
- To determine if ACAG can serve as a prognostic marker for all-cause and cardiovascular mortality in CRS.
Main Methods:
- Utilized data from the National Health and Nutrition Examination Survey (2005-2018) for 1783 CRS patients.
- Employed Cox regression, Kaplan-Meier curves, and restricted cubic spline analyses to assess mortality risks.
- Conducted subgroup analyses to evaluate consistency across different demographic and clinical characteristics.
Main Results:
- Higher ACAG levels were independently associated with increased risks of both all-cause mortality (HR=1.14, 95% CI: 1.09-1.18) and cardiovascular mortality (HR=1.14, 95% CI: 1.08-1.21).
- A significant linear dose-response relationship was observed between ACAG levels and mortality.
- These associations remained consistent across various subgroups.
Conclusions:
- Elevated ACAG is a significant predictor of higher all-cause and cardiovascular mortality in patients with CRS.
- ACAG represents a simple, accessible, and cost-effective biomarker for risk stratification in nephrology practice.
- This study is the first to demonstrate the prognostic utility of ACAG in the context of CRS.
Abstract:
The prognostic significance of the albumin-corrected anion gap (ACAG) in patients with cardiorenal syndrome (CRS) remains unclear. This study aimed to examine the association between ACAG and all-cause and cardiovascular mortality in a nationally representative cohort. We identified 1783 patients with CRS from the National Health and Nutrition Examination Survey 2005 to 2018 cycles and categorized them into terciles based on ACAG levels. Associations between ACAG and mortality were assessed using Cox regression, Kaplan-Meier survival curves, and restricted cubic spline analyses, with subgroup analyses across demographic and clinical strata. Among 1783 CRS patients, with a median follow-up time of 72 months, 859 deaths occurred, of which 36% were cardiovascular. Higher ACAG was independently associated with increased risks of all-cause mortality (hazard ratio [HR] = 1.14, 95% confidence interval [CI]: 1.09-1.18) and cardiovascular mortality (HR = 1.14, 95% CI: 1.08-1.21). A linear dose-response relationship was observed, and associations were consistent across subgroups. Elevated ACAG is significantly associated with higher risks of all-cause and cardiovascular mortality in CRS patients. To our knowledge, this is the first study to demonstrate the prognostic value of ACAG in CRS, highlighting its potential as a simple, inexpensive, and widely available marker for risk stratification in nephrology practice.
Related Concept Videos
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Nephrotic Syndrome I : Introduction
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Renal Regulation of Acid-Base Balance
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
Chronic Kidney Disease III: Interprofessional Care